Atomoxetine

Also known as: (R)-N-Methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine

Description

Atomoxetine is a highly selective and potent inhibitor of the pre-synaptic noradrenaline transporter, its presumed mechanism of action, without directly affecting the serotonin or dopamine transporters.

Medicine classification

ATC Code
Title
Class
N06BA09
Atomoxetine
N Nervous system → N06 Psychoanaleptics → N06B Psychostimulants, agents used for ADHD and nootropics → N06BA Centrally acting sympathomimetics

Medicines

Drug
Countries
ATAMA

Hong Kong

ATAMAX

Spain

ATOFAB

Austria

ATOMAID

United Kingdom

ATOMERRA

Australia

ATOMOTERA

Hong Kong

AUDALIS

Austria Netherlands

DEZAPREX

Spain

STRATTERA

Australia Austria Canada Cyprus Hong Kong

Product monographs

Monograph
Type
Country
STRATTERA Hard capsules
MPI, EU: SmPC
UK

2D Molecule Structure

2D representation of molecule

Unique Ingredient Identifier (UNII)

ASW034S0B8 - ATOMOXETINE

CAS Registry Number

83015-26-3 - atomoxetine

SNOMED-CT

407037005 - Atomoxetine (substance)

Usage: Next >